课题基金 / 基金详情

A tailored Care Home Clinical Assessment Tool (CHCAT) for front line clinicians

A tailored Care Home Clinical Assessment Tool (CHCAT) for front line clinicians
为一线临床医生量身定制的疗养院临床评估工具 (CHCAT)
批准号:
10083496
负责人:
金额:
$31.87万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
DemDx将提供急需的以疗养院为重点的临床评估工具(CHCAT)。需求的驱动因素是引入了增强的疗养院健康计划-旨在通过增加对疗养院护理人员、社区快速反应小组(主要由联合医疗专业人员(AHP)领导的一线临床支持)为年老体弱的疗养院居民提供更积极的卫生服务。疗养院护理人员和社区团队需要扩大对数百种条件、体征、症状和“危险信号”的通才知识,识别患者特定的合并症,以及对频繁更新的黄金标准方案的认识。这些临床医生迫切需要工具来支持他们发挥更大的作用。目前,社区和疗养院临床团队都严重依赖全科医生手术的临床指导(对全科医生工作量和等待名单的影响)或过度转介患者到急诊室,进一步给急性护理路径带来压力,包括救护车呼叫。CHCAT建立在DemDx行业领先的临床推理智能支持平台(CRISP)的基础上,该平台通过InnovateUK和NIHR资助的五个NHS信托基金共同开发。它是联合医疗专业人员支持工具的黄金标准。CHCAT将是一种革命性的基于云的临床评估工具,使用人工智能和数据来支持社区/疗养院工作人员进行更好、更安全、更快的临床评估和治疗或转诊决定。创新包括:*人工智能允许动态考虑经过验证的NICE数据中10,000种症状、合并症和“危险信号”的复杂模式和关联。*数据驱动的结构使AHP能够理解复杂的数据关联,以做出安全、一致的决定,并以患者为中心的数据权重允许对最可能的情况进行优先排序,向最佳转诊选项提供信息*由1200万名患者CPRD数据集提供支持。*输出针对5+种最常见疾病的特定于年龄的临床评估路径而量身定做*CHCAT完全可互操作,无缝集成到患者初级保健/急性路径中。
英文摘要
DemDx will deliver an urgently needed Care Home focused Clinical Assessment Tool (CHCAT).The need is driven by the introduction of the Enhanced Health in Care Homes initiative-aimed at providing a more proactive health service to the elderly and frail care home residents by increasing frontline clinical support to care home nursing staff, community rapid response teams led primarily by Allied Healthcare Professionals (AHPs).Care home nursing staff and communities teams require expanded generalist knowledge across hundreds of conditions, signs, symptoms and "red flags," recognition of patient-specific comorbidities, and awareness of frequently updated gold standard protocols. These clinicians are urgently calling for tools to support them in their expanded roles.Currently both community and care home clinical teams rely heavily on clinical guidance from GP surgeries (with knock on impact on GP workloads and waiting lists) or over-refer patients to A&E, putting further pressure on acute care pathways including ambulance call outs..CHCAT builds upon DemDx's sector-leading clinical reasoning intelligent support platform (CRISP), co-developed via InnovateUK and NIHR-funded engagement in five NHS Trusts. It is the gold standard in support tools for allied health professionals.CHCAT will be a revolutionary cloud-based clinical assessment tool, using AI and data to support community/care home staff in better, safer, quicker clinical assessment and treatment or referral decisions.Innovations include:* AI allowing dynamic consideration of complex patterns and associations across 10,000s of symptoms, comorbidities and "red flags" in validated NICE data.* A data-driven structure enabling AHPs to make sense of complex data associations to make safe, consistent decisions, with patient-centric data weighting enabling prioritisation of most probable conditions, to inform best referral options* Powered by a 12m-patient CPRD dataset.* Outputs are tailored to ageing-specific clinical assessment pathways for the 5+ most common ailments* CHCAT is fully interoperable, seamlessly integrated into patient primary care/acute pathways.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
基于CARE解码框架的跨范式肌电无声语音识别新方法
  • 批准号:
    2026JJ70025
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    谭欣
  • 依托单位:
CarE06介导朱砂叶螨对甲氰菊酯对映体代谢抗性形成差异机制
  • 批准号:
    CSTB2023NSCQ-MSX0916
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2023
  • 负责人:
    张平
  • 依托单位:
棉铃虫羧酸酯酶CarE001G在杀虫剂代谢和抗性中的作用及机制
  • 批准号:
    U1903111
  • 项目类别:
    联合基金项目
  • 资助金额:
    57万元
  • 批准年份:
    2019
  • 负责人:
    李永强
  • 依托单位:
棉铃虫羧酸酯酶CarE001C定向进化及突变酶的结构与功能研究
  • 批准号:
    31201517
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2012
  • 负责人:
    李永强
  • 依托单位: